Bruker Cellular Analysis, Inc.
Emeryville, CA
- UEI
- C1DAMF6GN5R5
- CAGE
- 8JBV9
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5858 Horton St #320, Emeryville, CA 94608, USA
- Website
- brukercellularanalysis.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $128,895 |
| FY2024 | $173,433 |
| FY2023 | $109,713 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Bruker Cellular Analysis, Inc., a self-certified small disadvantaged business registered in SAM.gov, is a corporate entity located in Emeryville, California, specializing in manufacturing advanced scientific research technologies and laboratory consumables. The company focuses on optofluidic platforms and single-cell analysis technologies, with a particular emphasis on developing sophisticated scientific research equipment for biomedical applications. Bruker Cellular Analysis, Inc. operates as a manufacturer of goods and has demonstrated significant capabilities in providing specialized laboratory equipment and consumables to federal agencies, particularly within the National Institutes of Health (NIH) ecosystem.
The company has secured multiple federal contract awards primarily from agencies like the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute on Aging (NIA), with contract values ranging from approximately $14,000 to $331,949. These contracts have predominantly been purchase orders for specialized laboratory consumables, including Single-Cell Secretome Adaptive Immune Chips, Optoselect Chips, Beacon Optofluidic System components, and service agreements such as the Beacon Essential Service Plan. Many of these contracts were directly tied to COVID-19 research efforts, supporting antibody discovery and development against SARS-CoV-2. The contracts were consistently awarded on a non-set-aside basis, indicating open competition, and the company has also participated in sub-contract work, such as a notable collaboration with the University of Texas MD Anderson Cancer Center. Bruker Cellular Analysis, Inc. has consistently demonstrated expertise in providing advanced scientific research technologies that support critical immunological and translational research initiatives.
Quick answers
Is Bruker Cellular Analysis, Inc. registered in SAM.gov?
Yes. Bruker Cellular Analysis, Inc.'s SAM.gov registration is active through October 23, 2027.
How much has Bruker Cellular Analysis, Inc. received in federal contracts?
Federal contracts obligated $128,895 to Bruker Cellular Analysis, Inc. in fiscal year 2025 and $412,041 in fiscal years 2023 through 2027.
What is Bruker Cellular Analysis, Inc.'s most recent federal award?
Bruker Cellular Analysis, Inc.'s most recent federal contract award is Laboratory consumable- single-cell secretome adaptive immune chips (human) (75N95D25P00119), from National Institute on Aging (NIH), on September 26, 2025.
On GovTribe
See Bruker Cellular Analysis, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors